• Dasatinib Monohydrate: Assay Reliability Guide

  2026-09-10

  This scenario-based guide explains how Dasatinib Monohydrate (SKU B5954) can support more interpretable cell viability, proliferation, and cytotoxicity assays. It connects kinase potency, DMSO handling, dose selection, NET-related biology, and practical vendor evaluation to chronic myeloid leukemia research and resistance studies.

• Bleomycin Sulfate: DNA Damage to Fibrosis

  2026-09-09

  Bleomycin Sulfate is more than a DNA strand break inducer: it can connect genotoxic injury with macrophage metabolism and fibrotic remodeling. This guide translates recent IGF2BP1–THBS1–TLR4 findings into practical assay design for oncology and pulmonary fibrosis research.

• Senescent Microglia in Aged Brain White Matter

  2026-09-09

  The reference study combines spatial transcriptomics, molecular imaging, and intervention experiments to identify a senescence- and disease-associated microglial state concentrated in the fimbria of naturally aged mouse brain. Its findings suggest that GAL3-positive white-matter microglia are regionally organized and partially reversible, providing a framework for studying early white-matter dysfunction without equating molecular association with causation.

• Arachidonic Acid in Ischemia-Reperfusion Assays

  2026-09-08

  Arachidonic Acid is a powerful mechanistic probe for studying lipid flux during cerebral ischemia-reperfusion. This article connects eicosanoid pathway analysis with a recent selective hypothermic perfusion study to improve assay design without overstating translational evidence.

• Cyanine 5-dCTP: From Label to DNA Architecture

  2026-09-08

  Fluorescent DNA labeling is increasingly becoming a systems-engineering challenge rather than a simple reagent choice. This thought-leadership article connects Cyanine 5-dCTP with emerging DNA-framework strategies, showing how molecular incorporation, enzyme accessibility, assay controls, and translational decision-making can be integrated into a more reliable workflow.

• JAK Inhibitors and Endothelial Cardiovascular Effects

  2026-09-07

  A 2025 comparative study tested six JAK inhibitors in cytokine-stimulated human endothelial cells and found a shared reduction in IL-6 but divergent effects on IL-8, adhesion molecules, coagulation markers, and apoptosis. Its side-by-side design shows why cardiovascular interpretation should consider inhibitor selectivity, concentration, and vascular endpoint rather than treating JAK inhibition as a uniform class effect.

• PDGF-BB and the Metabolic Logic of Vascular Remodeling

  2026-09-07

  A translational framework for using murine recombinant PDGF-BB to distinguish receptor-driven mitogenesis from lactate-linked metabolic remodeling in pulmonary vascular research.

• Asunaprevir (BMS-650032) HCV Assay Workflow

  2026-09-05

  Build a layered HCV research workflow around Asunaprevir (BMS-650032), moving from direct NS3/4A protease inhibition to cell-based HCV RNA replication inhibition. The article combines genotype-aware assay design, solvent and controls guidance, and a carefully bounded lesson from an orthogonal NUT carcinoma screening study.

• Spatial Translation Control in Cardiomyocytes

  2026-09-04

  Uchida and colleagues identify a compartment-specific mechanism in which mTORC1 and nuclear ERK regulate 4EBP1 phosphorylation to reposition translation within cardiomyocytes. The findings distinguish global translational activation from spatial control of protein synthesis and provide a mechanistic explanation for sarcomere deposition during concentric hypertrophy.

• Maraviroc (UK-427857) for Reliable Cell Assays

  2026-09-04

  Learn how Maraviroc (SKU A8311) can help researchers control CCR5-focused cell viability, proliferation, cytotoxicity, and HIV-1 entry workflows. This scenario-based guide covers solvent controls, protocol design, data interpretation, cross-domain limitations, and practical product selection.

• FDA Library Screening Finds Four MERS-CoV Inhibitors

  2026-09-03

  de Wilde and colleagues screened an FDA-approved compound collection and identified chloroquine, chlorpromazine, loperamide, and Lopinavir as low-micromolar inhibitors of MERS-CoV replication in cell culture. The study established a practical repurposing framework and showed activity across additional coronaviruses, while leaving questions about mechanism, in vivo efficacy, and clinical relevance unresolved.

• Kir2.1 Inhibition in Pulmonary Vascular Remodeling

  2026-09-03

  The reference study identifies KIR2.1 as a regulator of pulmonary artery smooth muscle cell proliferation and migration in pulmonary hypertension models. Its pharmacological experiments connect KIR2.1 inhibition with reduced OPN and PCNA expression and suppression of TGF-β1/SMAD2/3 signaling, providing a mechanistic framework for cardiovascular ion channel research.

• WSP-5: Making the H2S Deficit Visible

  2026-09-02

  A translational perspective on how WSP-5, or Washington State Probe-5, can connect deficient hydrogen sulfide biology with real-time cellular evidence in diabetic cardiomyopathy and related disease models.

• Cannabis Terpenes Activate A2A Receptors in Neuropathic Pain

  2026-09-02

  Schwarz et al. show that geraniol, linalool, β-pinene, α-humulene, and β-caryophyllene produce antinociception in mouse pain models through adenosine A2A receptor signaling rather than an assumed cannabinoid-receptor mechanism. The combination of behavioral pharmacology, spinal CRISPR knockdown, cellular assays, binding studies, and modeling provides a mechanistic framework for evaluating non-rewarding terpene analgesics.

• YC-1: Translational Control of Hypoxia Biology

  2026-09-01

  YC-1 is more than a conventional HIF-1α research tool: its soluble guanylyl cyclase activity and post-transcriptional suppression of HIF-1α create an opportunity to connect hypoxia signaling, vascular biology, tumor angiogenesis inhibition, and cancer research. This thought-leadership guide outlines how translational teams can use YC-1 while separating pathway effects, strengthening assay design, and avoiding overinterpretation.

7996 records 1/534 page Next 12345 下5页 Last page